Jan 15 (Reuters) - Eli Lilly (LLY.N), opens new tab said on ... The U.S. drugmaker struck a $3.2 billion deal last year to buy Morphic Holding in order to gain access to its experimental oral ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

Lilly to Buy Scorpion’s PI3Kα Inhibitor for ... of 2024 were Vertex’s buyout of Alpine Immune Sciences, Eli Lilly’s buyout of Morphic and Novo Nordisk’s acquisition of Catalent.

With every new year comes reflection and resolutions. But as we go to press well into January, it is worth a reminder that studies show nearly 90% ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

In addition, it is essential to note that Schrödinger is advancing strategic partnerships with companies such as Ajax Therapeutics, Morphic (acquired by Eli Lilly (NYSE: LLY)), Nimbus ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...